Conduit Pharmaceuticals Inc [CDT] stock prices are down -2.65% to $1.10 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CDT shares have gain 2.80% over the last week, with a monthly amount drifted -39.56%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
The stock price of Conduit Pharmaceuticals Inc [CDT] has been fluctuating between $0.98 and $392.00 over the past year. Conduit Pharmaceuticals Inc [NASDAQ: CDT] shares were valued at $1.10 at the most recent close of the market.
Analyzing the CDT fundamentals
Gross Profit Margin for this corporation currently stands at 0.54% with Operating Profit Margin at 0.02%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.13 and Total Capital is 0.02. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.95.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0600 points at the first support level, and at 1.0200 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.1400, and for the 2nd resistance point, it is at 1.1800.
Ratios To Look Out For
It’s worth pointing out that Conduit Pharmaceuticals Inc [NASDAQ:CDT]’s Current Ratio is 0.12. Further, the Quick Ratio stands at 0.12, while the Cash Ratio is 0.59.
Transactions by insiders
Recent insider trading involved Nirland Ltd, 10% Owner, that happened on Oct 03 ’24 when 1.5 million shares were sold. 10% Owner, Nirland Ltd completed a deal on Oct 04 ’24 to sell 1.37 million shares. Meanwhile, 10% Owner Nirland Ltd sold 0.94 million shares on Oct 07 ’24.
